| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
1.305 |
Evidence |
|
| GNAT2 |
GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit |
P2RY4 |
P2RY4, NRU: P2Y purinoceptor 4 |
1.305 |
Evidence |
|
| FER |
FER, TYK3: Proto-oncogene tyrosine-protein kinase FER |
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
1.305 |
Evidence |
|
| KCNA2 |
KCNA2: Potassium voltage-gated channel subfamily A member 2 |
TRPC3 |
N-terminally extended type 3 canonical transient receptor potential channel |
1.305 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
1.305 |
Evidence |
|
| CSPG2 |
IPI00009802 |
MMP13 |
MMP13: Collagenase 3 precursor |
1.305 |
Evidence |
|
| GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
1.305 |
Evidence |
|
| GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
MC4R |
MC4R: Melanocortin receptor 4 |
1.305 |
Evidence |
|
| GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
1.305 |
Evidence |
|
| C1S |
C1S: Complement C1s subcomponent precursor |
SERPINA10 |
SERPINA10, ZPI, UNQ707/PRO1358: Protein Z-dependent protease inhibitor precursor |
1.305 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
1.305 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
1.305 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
FPRL1 |
FPRL1, FPR2, FPRH1, LXA4R: FMLP-related receptor I |
1.305 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
1.305 |
Evidence |
|
| RHO |
RHO, OPN2: Rhodopsin |
GNAT2 |
GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit |
1.305 |
Evidence |
|
| ADRB2 |
ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor |
GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
1.305 |
Evidence |
O
|
| CFI |
CFI, IF: Complement factor I precursor |
SERPIND1 |
SERPIND1, HCF2: Heparin cofactor 2 precursor |
1.305 |
Evidence |
|
| CFI |
CFI, IF: Complement factor I precursor |
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
1.305 |
Evidence |
|
| CFI |
CFI, IF: Complement factor I precursor |
SERPINA4 |
SERPINA4, KST, PI4: Kallistatin precursor |
1.305 |
Evidence |
|
| CFI |
CFI, IF: Complement factor I precursor |
SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
1.305 |
Evidence |
|
| SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
CFI |
CFI, IF: Complement factor I precursor |
1.305 |
Evidence |
|
| SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
CFI |
CFI, IF: Complement factor I precursor |
1.305 |
Evidence |
|
| MYCN |
MYCN, NMYC: N-myc proto-oncogene protein |
AHR |
AHR: Aryl hydrocarbon receptor precursor |
1.305 |
Evidence |
|
| CSF2 |
CSF2, GMCSF: Granulocyte-macrophage colony-stimulating factor precursor |
IL12B |
IL12B, NKSF2: Interleukin-12 subunit beta precursor |
1.305 |
Evidence |
|
| COL4A1 |
IPI00021034 |
LIF |
LIF, HILDA: Leukemia inhibitory factor precursor |
1.305 |
Evidence |
|